653 results on '"Leppert, John T."'
Search Results
52. Kidney stone events following parathyroidectomy vs. non-operative management for primary hyperparathyroidism
53. Removing Race from eGFR calculations: Implications for Urologic Care
54. Basel Forebrain Neuronal Loss in Mice Lacking Neurotrophin Receptor p75
55. Risk of Postpartum Urinary Stone Disease in Women with History of Urinary Stone Disease During Pregnancy
56. Twenty-four-hour Urine Testing and Urinary Stone Disease Recurrence in Veterans
57. Association of Parathyroidectomy With 5-Year Clinically Significant Kidney Stone Events in Patients With Primary Hyperparathyroidism
58. PD25-04 A COST-EFFECTIVENESS VALIDATION OF THE 10-YEAR LIFE EXPECTANCY CUTOFF FOR AGGRESSIVE TREATMENT OF PROSTATE CANCER
59. Using an Automated Electronic Health Record Score To Estimate Life Expectancy In Men Diagnosed With Prostate Cancer In The Veterans Health Administration
60. PD47-12 THE CARE ASSESSMENT NEED (CAN) SCORE TO ESTIMATE LIFE EXPECTANCY IN PATIENTS DIAGNOSED WITH BLADDER CANCER IN THE VETERANS HEALTH ADMINISTRATION
61. Clinical laboratory tests associated with survival in patients with metastatic renal cell carcinoma: A Laboratory Wide Association Study (LWAS)
62. IMAGING OVERUSE PERSISTS IN POST-PROSTATECTOMY PATIENTS: PD06-03
63. Intraoperative Optical Biopsy during Robotic Assisted Radical Prostatectomy Using Confocal Endomicroscopy
64. Biochemical Measures of Diabetes are Not Independent Predictors of Urinary Incontinence in Women
65. Interaction between race and prostate cancer treatment benefit in the Veterans Health Administration
66. Development and Validation of an Interpretable Artificial Intelligence Model to Predict 10-Year Prostate Cancer Mortality
67. PD15-07 OPTICAL BIOPSY OF SUSPECTED PENILE CANCER USING CONFOCAL LASER ENDOMICROSCOPY: INITIAL FEASIBILITY STUDY
68. Biologic differences between peripheral and transition zone prostate cancer
69. Additional file 1 of Learning from the ���tail end��� of de-implementation: the case of chemical castration for localized prostate cancer
70. Kidney Stone Events Following Parathyroidectomy vs Nonoperative Management for Primary Hyperparathyroidism.
71. Postoperative opioid-free ureteroscopy discharge: A quality initiative pilot protocol
72. Evaluation of Patient Treatment Preferences for 15 to 20 mm Kidney Stones: A Conjoint Analysis
73. Costs of Robotic-Assisted Radical Prostatectomy 1 Year After Surgery
74. Osteoporosis, Fractures, and Bone Mineral Density Screening in Veterans With Kidney Stone Disease
75. Following Up on an Improperly Drawn Screening Test: The PSA Dilemma
76. Editorial Commentary
77. Testing for Primary Aldosteronism and Mineralocorticoid Receptor Antagonist Use Among U.S. Veterans
78. The Chemokine Receptor CXCR3 is an Independent Prognostic Factor in Patients With Localized Clear Cell Renal Cell Carcinoma
79. In Vivo Efficacy of Laparoscopic Assisted Percutaneous Renal Cryotherapy: Evidence Based Guidelines for the Practicing Urologist
80. Multiregion Quantification of Extracellular Signal-regulated Kinase Activity in Renal Cell Carcinoma
81. Utilization of cytoreductive nephrectomy and patient survival in the targeted therapy era
82. In Search of Clinical Biomarkers of Response to Checkpoint Inhibitor Therapy in Renal Cell Carcinoma
83. Facility-Level Variation in Dialysis Use and Mortality Among Older Veterans With Incident Kidney Failure
84. Systematic evaluation of environmental and behavioural factors associated with all-cause mortality in the United States National Health and Nutrition Examination Survey
85. Learning From the 'Tail End' of De-implementation: The Case of Chemical Castration for Localized Prostate Cancer
86. Association of 152 Biomarker Reference Intervals with All-Cause Mortality in Participants of a General United States Survey from 1999 to 2010
87. Novel approaches in the therapy of metastatic renal cell carcinoma
88. Surveillance following radical or partial nephrectomy for renal cell carcinoma
89. Laboratory‐wide association study of survival with prostate cancer
90. Development of a DNA Methylation–Based Diagnostic Signature to Distinguish Benign Oncocytoma From Renal Cell Carcinoma
91. Life expectancy estimates for patients diagnosed with prostate cancer in the Veterans Health Administration
92. Analysis of Primary Hyperparathyroidism Screening Among US Veterans With Kidney Stones
93. Turning on the Lights: New Technologies in Optical Diagnostics and Therapeutics
94. Prevention of Bladder Cancer: A Review
95. RENCA/carbonic anhydrase-IX: A murine model of a carbonic anhydrase-IX-expressing renal cell carcinoma
96. Implants of noninvasive papillary urothelial carcinoma in peritoneum and ileocolonic neobladder: Support for “seed and soil” hypothesis of bladder recurrence
97. The m 6 A RNA demethylase FTO is a HIF-independent synthetic lethal partner with the VHL tumor suppressor
98. The Urine Albumin-to-Creatinine Ratio and Kidney Function after Nephrectomy
99. Urinary Stone Disease in Pregnancy: Current Management Practices in a Large National Cohort
100. Abstract C053: Testicular cancer in Hispanics: Incidence of subtypes over time according to neighborhood sociodemographic factors in California
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.